Search clinical trials for: ZD6474
Total 71 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant NeoplasmUnited States
-
Genzyme, a Sanofi CompanyCompletedNon Small Cell Lung CancerUnited States, Australia, Brazil, France, Italy, Korea, Republic of, Mexico, Spain, United Kingdom, Philippines, China, Germany, Norway, Canada, Hong Kong, Argentina, Netherlands, Taiwan, India, Thailand, Indonesia, Denmark
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States, Italy, South Africa, Spain, Finland, France, Germany, India, Thailand
-
M.D. Anderson Cancer CenterUnited States Department of Defense; AstraZenecaCompleted
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States
-
National Cancer Institute (NCI)TerminatedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States
-
Hoosier Cancer Research NetworkAstraZenecaCompletedSmall Cell Lung CancerUnited States
-
SanofiTerminatedNon-small Cell Lung Cancer (NSCLC)Netherlands
-
Genzyme, a Sanofi CompanyCompleted
-
Ronald WeigelAstraZenecaTerminatedInvasive Breast CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Terminated
-
Aegerion Pharmaceuticals, Inc.Completed
-
PrECOG, LLC.AstraZenecaCompletedLung Cancer | Non Small Cell Lung CancerUnited States
-
Genzyme, a Sanofi CompanyTerminatedMesotheliomaGermany, Switzerland
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, HepatocellularTaiwan
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
Genzyme, a Sanofi CompanyCompletedBreast Neoplasms | Metastases, NeoplasmSpain, United States
-
M.D. Anderson Cancer CenterUnited States Department of Defense; AstraZenecaTerminated
-
National Cancer Institute (NCI)Terminated
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's HospitalCompletedMetastatic Breast CancerUnited States
-
M.D. Anderson Cancer CenterAstraZenecaTerminatedNeuroblastomaUnited States
-
M.D. Anderson Cancer CenterAstraZenecaTerminated
-
Genzyme, a Sanofi CompanyWorldwide Clinical TrialsCompletedSymptomatic, Aggressive, Sporadic, Unresectable, Locally | Advanced/Metastatic Medullary Thyroid Cancer (MTC)Belgium, Italy, Netherlands, Spain, France, Germany, United Kingdom, Luxembourg
-
National Cancer Institute (NCI)CompletedRenal Cancer | Von Hippel LindauUnited States
-
National Cancer Institute (NCI)CompletedRecurrent High-Grade Gliomas | Malignant Gliomas | Progressive Low-Grade GliomasUnited States
-
Genzyme, a Sanofi CompanyCompletedLung Cancer | Non Small Cell Lung CancerUnited States, Australia, France, Italy, South Africa, Spain, United Kingdom, Sweden, Philippines, Germany, Hong Kong, Argentina, Israel, Portugal, Greece, Taiwan, Mexico, Belgium, Venezuela, Colombia, India
-
Fox Chase Cancer CenterAstraZenecaCompletedCancer of the Esophagus | Adenocarcinoma of the Gastroesophageal Junction | Cancer of the StomachUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedPrecancerous Condition | Lip and Oral Cavity Squamous Cell Carcinoma | Oral Cavity Verrucous CarcinomaUnited States
-
Patrick Y. Wen, MDMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Dana-Farber... and other collaboratorsCompletedGlioblastoma Multiforme | GliosarcomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; AstraZe... and other collaboratorsCompletedTransitional Cell Carcinoma | Bladder CancerUnited States
-
Stanford UniversityAstraZenecaTerminated
-
Genzyme, a Sanofi CompanyCompletedUnresectable Locally Advanced or Metastatic, Medullary Thyroid CarcinomaJapan
-
Genzyme, a Sanofi CompanyCompletedColorectal CancerUnited States, Korea, Republic of, Spain, United Kingdom, Norway, Argentina
-
Genzyme, a Sanofi CompanyCompletedLung Cancer | Non-small Cell Lung CancerVietnam, United States, Brazil, France, Italy, Korea, Republic of, Mexico, Spain, Turkey, Germany, China, Japan, Netherlands, Argentina, Austria, Belgium, Canada, Portugal, Greece, India, Denmark, Malaysia, Indonesia, Thailand, Singapore
-
Yonsei UniversityCompleted
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States, South Africa, United Kingdom, Germany, Argentina, Belgium
-
Leonard ApplemanAstraZenecaCompletedAdvanced Incurable Solid MalignancyUnited States
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerUnited States, France
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; AstraZe...CompletedColorectal CancerUnited States
-
M.D. Anderson Cancer CenterAstraZenecaTerminatedNon-Small Cell Lung CancerUnited States
-
Genzyme, a Sanofi CompanyCompletedNon Small Cell Lung CancerItaly
-
SanofiCompletedPancreatic CancerSwitzerland
-
Genzyme, a Sanofi CompanyCompletedColorectal CancerGermany
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyActive, not recruitingThyroid CancerUnited States, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark, France, Germany, Hungary, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, Serbia, Spain, Sweden, Switz...
-
Annick DesjardinsAstraZenecaCompletedGlioblastoma | GliosarcomaUnited States
-
Annick DesjardinsAstraZeneca; Novartis PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerItaly, Spain, Romania, Netherlands, Canada, United States, Switzerland, Australia